ARCHIVES

Generic Paclitaxel Approval Withstands Court Challenge.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991